K Poláková
About
In The Last Decade
K Poláková
78 papers receiving 763 citations
Peers
Comparison fields: 5 of 85
- Immunology 385
- Molecular Biology 174
- Epidemiology 170
- Radiology, Nuclear Medicine and Imaging 110
- Public Health, Environmental and Occupational Health 93
Countries citing papers authored by K Poláková
This map shows the geographic impact of K Poláková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Poláková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Poláková more than expected).
Fields of papers citing papers by K Poláková
This network shows the impact of papers produced by K Poláková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Poláková. The network helps show where K Poláková may publish in the future.
Co-authorship network of co-authors of K Poláková
This figure shows the co-authorship network connecting the top 25 collaborators of K Poláková. A scholar is included among the top collaborators of K Poláková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Poláková. K Poláková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 12 | |
| 4 | 5 | |
| 5 | 8 | |
| 6 | 3 | |
| 7 | 16 | |
| 8 | 7 | |
| 9 | Účinky topického imunomodulátoru (imiquimodu) v léčbě aktinické keratózy | 1 |
| 10 | 21 | |
| 11 | 13 | |
| 12 | 24 | |
| 13 | THE EFFECT OF DIFFERENT YEAST STRAINS ON MILK YIELD, FATTY ACIDS PROFILE AND PHYSIOLOGICAL PARAMETERS IN DAIRY COWS | 1 |
| 14 | 6 | |
| 15 | 27 | |
| 16 | Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. III. Reactivity with human convalescent sera. | 18 |
| 17 | Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. IV. Immunogenic properties of separated haemagglutinin glycopolypeptides. | 10 |
| 18 | Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. I. Gel filtration in 6 M guanidine hydrochloride. | 3 |
| 19 | Radioimmunoassay of influenza A virus haemagglutinin. I. Preparation and properties of radioactive 125I-labelled bromelain-released haemagglutinin. | 11 |
| 20 | A competitive-inhibition radioimmunoassay for influenza virus envelope antigens. | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.